Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The European School of Oncology (ESO) is an independent, non-profit organization dedicated to the education and training of oncology professionals worldwide. Founded in 1982 by Umberto Veronesi, ESO aims to reduce cancer mortality and improve patient care through high-quality medical education. The organization offers a diverse range of programs, including masterclasses, certificate of competence programs, e-learning modules, and clinical fellowships. ESO also publishes "Cancer World," a magazine focusing on cancer policy and patient-centered care. It operates as a key pillar in the European oncological community, collaborating with major international societies to standardize and advance cancer treatment knowledge.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on European School of Oncology.